Iuliana Shapira, MD
Hematology & Oncology · Little Silver, NJNPI 1760553762
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,233 of the $46,074 with a category attached, or 83.0%. 34 manufacturers reported payments, led by Daiichi Sankyo Inc. at 26.0% of the total. Reporting peaked in 2021 at $14,392 and has fallen 80.4% since, to $2,823 in 2025. Among hematology & oncology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $639.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$12K
- AstraZeneca$6K
- Sanofi$4K
- Beigene USA, Inc.$3K
- Astellas Pharma US Inc$2K
- Foundation Medicine, Inc.$2K
- plus $17K from 28 others
Across 122 payments — averaging $4896.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$210K
- Epizyme, Inc.$127K
- Jazz Pharmaceuticals Inc.$48K
- Argenx US, Inc.$43K
- AbbVie$41K
- Bristol Myers Squibb$25K
- plus $103K from 6 others
What the payments were for
- Consulting fees$38,23383%
- Speaking & faculty fees$6,20913%
- Food & beverage$1,3773%
- Education$2561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $11,981 |
| AstraZeneca | 5 | $5,804 |
| Sanofi | 4 | $3,616 |
| Beigene USA, Inc. | 2 | $3,375 |
| Astellas Pharma US Inc | 4 | $2,296 |
| Foundation Medicine, Inc. | 2 | $2,282 |
| Pfizer | 1 | $2,250 |
| Eisai Inc. | 3 | $2,198 |
| Morphosys, US Inc. | 1 | $2,160 |
| Johnson & Johnson | 5 | $1,428 |
| Janssen Scientific Affairs, LLC | 1 | $1,388 |
| Seagen Inc. | 1 | $1,245 |
| Blueprint Medicines Corporation | 1 | $1,244 |
| Jazz Pharmaceuticals Inc. | 1 | $1,100 |
| Coherus Oncology, Inc. | 1 | $1,100 |
| Tolmar Pharmaceuticals, Inc. | 1 | $1,020 |
| Pharmacosmos Therapeutics Inc. | 1 | $660 |
| ASD Specialty Healthcare, LLC | 1 | $203 |
| Amgen | 3 | $130 |
| Regeneron | 1 | $108 |
| GSK | 1 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Exelixis Inc. | 2 | $60 |
| Merck | 3 | $53 |
| Genentech USA, Inc. | 2 | $44 |
| Tesaro, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| AbbVie | 1 | $14 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,074 in reported general payments places this provider in the 90th percentile of 362 hematology & oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Little Silver
- Denis FitzgeraldLittle Silver$21K
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
- Carl HenningsonManasquan$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.